Metformin administration in prevention of colorectal polyps in type 2 diabetes mellitus patients

Figure 1 Study flow chart. DM: Diabetes mellitus.

Figure 2 Comparison of the complications, drug history, and history of smoking and drinking between type 2 diabetes mellitus patients with and without colorectal polyps. CAD: Coronary artery disease.

Figure 3 Multivariate logistic regression analysis of colorectal polyps. LDL-C: Low-density lipoprotein cholesterol.

Figure 4 Comparison of the duration of metformin use between type 2 diabetes mellitus patients with and without colorectal polyps.

Figure 5 Comparison of the size and number of polyps between patients with and without metformin use.

Figure 6 Multivariate logistic regression analysis of adenoma. BMI: Body mass index.

Figure 7 Comparison of polyps between patients with and without metformin use during interval colonoscopy.